Tag Archives: Lars Fruergaard

Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue on Wednesday that comfortably beat Wall Street expectations. But the drugmaker said it expected sales growth to slow in 2025, as competition increases. Novo Nordisk retains its title as Europe’s most valuable company, but its share price has dropped about …